Exclusive: Two London hospital trusts to trial tool that can predict those at risk up to 13 years before condition develops
The NHS in England is launching a world-first trial of a “gamechanging” artificial intelligence tool that can identify patients at risk of type 2 diabetes more than a decade before they develop the condition.
More than 500 million people worldwide have type 2 diabetes, and finding new ways to spot people at risk before they develop the condition is a major global health priority. Estimates suggest 1 billion people will have type 2 diabetes by 2050.
